Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Andrew Boyle, MD

877.463.2010

Andrew Boyle, MD

Appointed: 2012

Andrew Boyle, MD
Department: Cardiovascular Medicine
Department Chair
Location: Florida, Weston
Mail Code BOX 718
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
WorkFax:954.659.5291
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Andrew J. Boyle, MD, is chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic Florida. He specializes in the medical management of heart transplant patients, mechanical circulatory support, heart failure and cardiomyopathy. Dr. Boyle is a member of Cleveland Clinic Florida’s new transplant team and he will oversee the heart transplant program.

Dr. Boyle is certified by the American Board of Internal Medicine in both cardiovascular disease and heart failure and transplant cardiology. He is a Fellow of the American College of Cardiology. He is also a member of the Heart Failure Society of America and the International Society of Heart and Lung Transplant.

After earning his medical degree from the University of Ottawa in Ontario, Canada, Dr. Boyle completed his internal medicine residency at the Mayo Clinic in Rochester, Minnesota and fellowships in cardiovascular disease and heart failure transplantation at the Cleveland Clinic Foundation in Ohio.

Professional Highlights

ACADEMIC POSITION

  • 2012 – current Chief of Cardiology, Cleveland Clinic Florida
  • 2009 – 2012 - Aurora St. Luke’s Medical Center, Division of Cardiology
  • 2011 – 2012 - University of Wisconsin Department of Medicine, Clinical Associate Profession of Medicine
  • 2008 – 2009 - University of Minnesota Department of Medicine, Division of Cardiology Associate Professor of Medicine
  • 2002 – 2008 - University of Minnesota Department of Medicine, Division of Cardiology Assistant Professor of Medicine

ADMINISTRATION

  • 2013 – current - Heart and Vascular Institute Center Director, Cleveland Clinic Florida
  • 2012 – current - Chief of Cardiology, Cleveland Clinic Florida
  • 2013 – current - Primary Heart Transplant Physician, Cleveland Clinic Florida
  • 2009 – 2012 - Medical Director of Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support, Aurora St. Luke’s Medical Center
  • 2009 – 2012 - Heart Failure Fellowship Program Director, Aurora St. Luke’s Medical Center
  • 2008- 2009 - Medical Director of Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support, University of Minnesota
  • 2004 – 2006 - Medical Director of Inpatient Cardiology, University of Minnesota Medical Center

Education & Fellowships

Fellowship - Cleveland Clinic
Cardiology, Heart Failure Transplantation
Cleveland, OH USA
2002
Fellowship - Cleveland Clinic
Cardiovascular Disease
Cleveland, OH USA
2001
Residency - Mayo Clinic
Phoenix, AZ USA
1998
Medical School - University of Ottawa Faculty of Medicine
Ottawa, Ontario Canada
1995
Undergraduate - McGill University
Montreal, Quebec Canada
1991

Certifications

  • Internal Medicine- Cardiovascular Disease
  • Internal Medicine- Advanced Heart Failure and Transplant Cardiology

Specialty Interests

Advanced Heart Failure Cardiac Resynchronization Therapy Cardiac Transplantation Mechanical Circulatory Support (LVADs)

Awards & Honors

  • 2006 - University of Minnesota Medical Center Educational Excellence Award

Memberships

  • International Society of Heart and Lung Transplant: 2002- current
  • Heart Failure Society of America: 2002 - current

Treatment & Services

  • Abnormal Stress Test
  • Adult General Clinical Cardiology
  • Cardiac Critical Care
  • Cardiopulmonary Exercise Testing
  • Diagnostic Clinical Cardiology
  • Endomyocardial Biopsy
  • General Cardiology
  • Intra-aortic Balloon Pumping
  • Mechanical Assist Devices
  • Second Opinion
  • Swan-Ganz Catheterization
  • Ventricular Assist Device

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/9/2014, Dr. Boyle has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Boyle receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Medtronic, Inc.
  • Thoratec Corporation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • French